In ovarian cancer, NEAT1 is elevated and increases paclitaxel resistance of ovarian cancer via upregulating zinc finger E-box-binding homeobox 1 (ZEB1) expression by sponging miR-194 [18]. Here, NEAT1 is linked to ovarian carcinoma.